
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9205021
[patent_doc_number] => 20140004198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'GLP-1 PARTICLES AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/980166
[patent_app_country] => US
[patent_app_date] => 2012-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13773
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980166
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980166 | GLP-1 PARTICLES AND COMPOSITIONS | Jan 18, 2012 | Abandoned |
Array
(
[id] => 9307080
[patent_doc_number] => 20140045754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'GLP-1 COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/980147
[patent_app_country] => US
[patent_app_date] => 2012-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12202
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980147 | GLP-1 COMPOSITIONS | Jan 18, 2012 | Abandoned |
Array
(
[id] => 8301023
[patent_doc_number] => 20120183582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'Oral Delivery of Peptides'
[patent_app_type] => utility
[patent_app_number] => 13/342133
[patent_app_country] => US
[patent_app_date] => 2012-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12102
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13342133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/342133 | Oral Delivery of Peptides | Jan 1, 2012 | Abandoned |
Array
(
[id] => 9413614
[patent_doc_number] => 08697651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Amyloid β fibrillogenesis-inhibiting peptide'
[patent_app_type] => utility
[patent_app_number] => 13/328315
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7055
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328315 | Amyloid β fibrillogenesis-inhibiting peptide | Dec 15, 2011 | Issued |
Array
(
[id] => 9046821
[patent_doc_number] => 08541375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Glycopeptide phosphonate derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/328284
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23319
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328284
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328284 | Glycopeptide phosphonate derivatives | Dec 15, 2011 | Issued |
Array
(
[id] => 8128343
[patent_doc_number] => 20120088716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'Polypeptide Protracting Tags'
[patent_app_type] => utility
[patent_app_number] => 13/327378
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27053
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088716.pdf
[firstpage_image] =>[orig_patent_app_number] => 13327378
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/327378 | Polypeptide protracting tags | Dec 14, 2011 | Issued |
Array
(
[id] => 10169337
[patent_doc_number] => 09200038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Cyclosporine analogue molecules modified at amino acid 1 and 3'
[patent_app_type] => utility
[patent_app_number] => 13/994707
[patent_app_country] => US
[patent_app_date] => 2011-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18571
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994707
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994707 | Cyclosporine analogue molecules modified at amino acid 1 and 3 | Dec 13, 2011 | Issued |
Array
(
[id] => 8173584
[patent_doc_number] => 20120108519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'NEO-TRYPTOPHAN'
[patent_app_type] => utility
[patent_app_number] => 13/324976
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16584
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108519.pdf
[firstpage_image] =>[orig_patent_app_number] => 13324976
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324976 | NEO-TRYPTOPHAN | Dec 12, 2011 | Abandoned |
Array
(
[id] => 9160971
[patent_doc_number] => 20130309247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'DIMERIC IAP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/993198
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28382
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993198
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993198 | Dimeric IAP inhibitors | Dec 12, 2011 | Issued |
Array
(
[id] => 9081060
[patent_doc_number] => 20130266590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'DIMERIC IAP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/993180
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20485
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993180 | DIMERIC IAP INHIBITORS | Dec 12, 2011 | Abandoned |
Array
(
[id] => 8496429
[patent_doc_number] => 20120295837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'NOVEL ANTIMICROBIAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/314288
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 29061
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314288
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314288 | NOVEL ANTIMICROBIAL AGENTS | Dec 7, 2011 | Abandoned |
Array
(
[id] => 8265823
[patent_doc_number] => 20120165252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Method of Regulating Glucose Metabolism, and Reagents Related Thereto'
[patent_app_type] => utility
[patent_app_number] => 13/297522
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19230
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297522
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/297522 | Method of regulating glucose metabolism, and reagents related thereto | Nov 15, 2011 | Issued |
Array
(
[id] => 9869257
[patent_doc_number] => 08957028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-17
[patent_title] => 'Red-shifted opsin molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/295750
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 20352
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/295750 | Red-shifted opsin molecules and uses thereof | Nov 13, 2011 | Issued |
Array
(
[id] => 9882748
[patent_doc_number] => 08969513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Caspofungin analog and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 13/884750
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9339
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884750 | Caspofungin analog and applications thereof | Nov 9, 2011 | Issued |
Array
(
[id] => 9923084
[patent_doc_number] => 08981048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-17
[patent_title] => 'Caspofungin analog, and preparation method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/884775
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8498
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884775 | Caspofungin analog, and preparation method and uses thereof | Nov 9, 2011 | Issued |
Array
(
[id] => 9016493
[patent_doc_number] => 20130231457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'PREPARATION METHOD FOR CASPOFUNGIN'
[patent_app_type] => utility
[patent_app_number] => 13/884686
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5158
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884686
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884686 | Preparation method for caspofungin | Nov 9, 2011 | Issued |
Array
(
[id] => 9503522
[patent_doc_number] => 08741835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment'
[patent_app_type] => utility
[patent_app_number] => 13/287211
[patent_app_country] => US
[patent_app_date] => 2011-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 16835
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13287211
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/287211 | Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment | Nov 1, 2011 | Issued |
| 13/287102 | COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS | Oct 31, 2011 | Abandoned |
Array
(
[id] => 7807999
[patent_doc_number] => 20120058953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 13/274142
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25711
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058953.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274142
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274142 | COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS | Oct 13, 2011 | Abandoned |
Array
(
[id] => 10893070
[patent_doc_number] => 08916683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'Nanostructured physically-associating hydrogels for injectable, responsive, and tough biomaterials'
[patent_app_type] => utility
[patent_app_number] => 13/253485
[patent_app_country] => US
[patent_app_date] => 2011-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 30
[patent_no_of_words] => 13285
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13253485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/253485 | Nanostructured physically-associating hydrogels for injectable, responsive, and tough biomaterials | Oct 4, 2011 | Issued |